Invention Grant
- Patent Title: Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines
-
Application No.: US15122241Application Date: 2015-03-04
-
Publication No.: US10246508B2Publication Date: 2019-04-02
- Inventor: Adi Mor
- Applicant: CHEMOMAB LTD.
- Applicant Address: IL Tel Aviv
- Assignee: CHEMOMAB LTD.
- Current Assignee: CHEMOMAB LTD.
- Current Assignee Address: IL Tel Aviv
- Agency: Vorys, Sater, Seymour and Pease LLP
- International Application: PCT/IL2015/050234 WO 20150304
- International Announcement: WO2015/132790 WO 20150911
- Main IPC: C07K16/24
- IPC: C07K16/24 ; C07H21/04 ; C12N15/85 ; A61K39/00
Abstract:
Provided are isolated polyspecific antibodies directed to a unique epitope in the chemokine eotaxin 2. The antibodies bind additional CCR3-binding chemokines. Further provided are methods for using of the antibodies for attenuating the migration of various cells and for treating fibrotic diseases, autoimmune inflammatory disorders, monocyte related disorders or allergic atopic disorders.
Public/Granted literature
- US20160368979A1 ANTI EOTAXIN-2 ANTIBODIES THAT RECOGNIZE ADDITIONAL CCR3-BINDING CHEMOKINES Public/Granted day:2016-12-22
Information query
